In a previous study, intranasal insulin therapy improved cognitive function and slowed cognitive decline [32] and the insulin sensitizer, pioglitazone, showed time- and dose-dependent effects for preventing the development of dementia in patients with diabetes [33]. This evidence concerns the gene INS and dementia.